These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3470737)

  • 1. Mechanism of carboxypeptidase A: hydration of a ketonic substrate analogue.
    Christianson DW; David PR; Lipscomb WN
    Proc Natl Acad Sci U S A; 1987 Mar; 84(6):1512-5. PubMed ID: 3470737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex between carboxypeptidase A and a hydrated ketomethylene substrate analogue.
    Shoham G; Christianson DW; Oren DA
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):684-8. PubMed ID: 3422451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of a possible transition state analogue to the active site of carboxypeptidase A.
    Christianson DW; Lipscomb WN
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6840-4. PubMed ID: 3863130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Bromo ketone substrate analogues are powerful reversible inhibitors of carboxypeptidase A.
    Galardy RE; Kortylewicz ZP
    Biochemistry; 1985 Dec; 24(26):7607-12. PubMed ID: 4092028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature.
    Christianson DW; Lipscomb WN
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7568-72. PubMed ID: 3463986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc environment and cis peptide bonds in carboxypeptidase A at 1.75-A resolution.
    Rees DC; Lewis M; Honzatko RB; Lipscomb WN; Hardman KD
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3408-12. PubMed ID: 6943549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes.
    Kim H; Lipscomb WN
    Biochemistry; 1990 Jun; 29(23):5546-55. PubMed ID: 2386784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19F nuclear magnetic resonance spectroscopy study of the complex of 2-benzyl-4-oxo-5,5,5-trifluoropentanoic acid and carboxypeptidase A.
    Teater C; Grobelny D; Galardy RE
    Biochem Biophys Res Commun; 1988 Jun; 153(2):773-8. PubMed ID: 3382403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of carboxypeptidase A by aldehyde and ketone substrate analogues.
    Galardy RE; Kortylewicz ZP
    Biochemistry; 1984 Apr; 23(9):2083-7. PubMed ID: 6547054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of an effective mechanism-based inactivator for a zinc protease.
    Mobashery S; Ghosh SS; Tamura SY; Kaiser ET
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):578-82. PubMed ID: 2300547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural comparison of sulfodiimine and sulfonamide inhibitors in their complexes with zinc enzymes.
    Cappalonga AM; Alexander RS; Christianson DW
    J Biol Chem; 1992 Sep; 267(27):19192-7. PubMed ID: 1527041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of an actively exchanging complex between carboxypeptidase A and a substrate analogue.
    Rees DC; Honzatko RB; Lipscomb WN
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3288-91. PubMed ID: 6932021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics characterization of the active cavity of carboxypeptidase A and some of its inhibitor adducts.
    Banci L; Schröder S; Kollman PA
    Proteins; 1992 Aug; 13(4):288-305. PubMed ID: 1518800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of carboxypeptidase A by excess zinc: analysis of the structural determinants by X-ray crystallography.
    Gomez-Ortiz M; Gomis-Rüth FX; Huber R; Avilés FX
    FEBS Lett; 1997 Jan; 400(3):336-40. PubMed ID: 9009226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pH on the structure and function of carboxypeptidase A: crystallographic studies.
    Shoham G; Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7767-71. PubMed ID: 6595659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of carboxypeptidase A by ketones and alcohols that are isosteric with peptide substrates.
    Grobelny D; Goli UB; Galardy RE
    Biochemistry; 1985 Dec; 24(26):7612-7. PubMed ID: 4092029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode.
    Arolas JL; Popowicz GM; Lorenzo J; Sommerhoff CP; Huber R; Aviles FX; Holak TA
    J Mol Biol; 2005 Jul; 350(3):489-98. PubMed ID: 15961103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A.
    Wang SF; Tian GR; Zhang WZ; Jin JY
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5009-11. PubMed ID: 19646864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
    Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
    J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoro ketone inhibitors of hydrolytic enzymes.
    Gelb MH; Svaren JP; Abeles RH
    Biochemistry; 1985 Apr; 24(8):1813-7. PubMed ID: 2990541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.